Aurobindo Pharma reported INR5.39B in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Cipla CIPLA:IN INR 10.03B 1.14B
Dr.Reddys Laboratories DRRD:IN INR 15.9B 9.5B
Hindustan Unilever HUVR:IN INR 31.44B 350M
Sun Pharmaceuticals SUNP:IN INR 25.88B 4.37B
UPL UPLL:IN INR 21.17B 4.4B